The pro-tumorigenic host response to cancer therapies

Shaked, Y

Shaked, Y (reprint author), Technion Israel Inst Technol, Technion Integrated Canc Ctr, Dept Cell Biol & Canc Sci, Haifa, Israel.

NATURE REVIEWS CANCER, 2019; 19 (12): 667

Abstract

Resistance to cancer therapy remains a major challenge in clinical oncology. Although the initial treatment phase is often successful, eventual resist......

Full Text Link